CIHR – Joint Canada-Israel Health Research Program Phase II (2021 funding opportunity) – Registration
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire within your unit
Memorial Deadline: No RGCS review required for the Registration
External Deadline: Thursday 3rd, March 2022
Description
Important Dates
| Competition | 202204JCI |
|---|---|
| Registration Deadline | 2022-03-03 |
| Application Deadline | 2022-04-05 |
| Anticipated Notice of Decision | 2022-08-16 |
| Funding Start Date | 2022-11-01 |
Phase II of the Joint Canada-Israel Health Research Program (the Program) seeks to support fundamental research at the cutting-edge of biomedical science and global health. This first call for proposals under phase II is directed toward proposals at the intersection between non-communicable chronic disease (NCD) and infectious diseases while strengthening capacity in Canada, Israel and in low and middle income countries (LMIC).
The Program will support world-class research teams co-led by three principal investigators: one from Canada, one from Israel and one from an LMIC (see Appendix A for the list of eligible countries). The teams will integrate researchers from all three geographies with the intention of strengthening scientific capacity, promoting collaboration, equitable partnerships and scientific excellence in all its diversity. It is expected that the three principal investigators will work together on a cohesive research project with researchers from all three geographies contributing to and benefiting from their involvement in the project and the Program.
Additional information can be found at ResearchNet.